Press release
Anti-Diuretic Drugs Market: 2024 Industry Size, Shares, Segment & Forecast up to 2032
Anti-Diuretic Drugs Market
Anti-diuretic drugs are primarily used to treat diabetes insipidus, a condition caused by low levels of the antidiuretic hormone (ADH) in the body. These drugs play a vital role in managing the excessive urination and thirst associated with the condition. With advancements in medical technology, clinical trials for anti-diuretic drugs have progressed significantly, making the treatment more effective for patients with diabetes insipidus.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2907
Key Market Drivers
One of the main factors driving the growth of the anti-diuretic drugs market is the rising number of diabetes cases globally. According to the International Diabetes Federation (IDF), around 537 million adults worldwide live with diabetes, and this number is expected to reach 783 million by 2045. The increasing prevalence of diabetes is expected to raise the demand for anti-diuretic drugs in the coming years.
Additionally, leading pharmaceutical companies are upgrading their product portfolios, which is also contributing to market growth. For example, Amphastar Pharmaceuticals, Inc. received FDA approval in July 2022 for its Vasopressin injection, a drug used in treating conditions like diabetes insipidus. These new product launches and approvals are expected to strengthen the market's growth trajectory.
Another key growth driver is the rising demand for desmopressin analogs, which are synthetic forms of the vasopressin hormone. Desmopressin is used to manage dehydration, control excessive urination, and reduce increased thirst. The availability of desmopressin in various forms, such as nasal sprays and tablets, has made it easier for healthcare providers and patients to adopt the treatment, further driving the market's expansion.
Geriatric Population and Rising Diabetes Insipidus Cases
The aging population is also a significant factor in the growth of the anti-diuretic drugs market. Older individuals are more prone to conditions like diabetes insipidus, and the rising life expectancy is increasing the demand for effective treatment options. According to the World Health Organization, by 2030, 1 in 6 people worldwide will be aged 60 years or older, with the number doubling to 2.1 billion by 2050. This growing elderly population, particularly those affected by diabetes insipidus, is driving market growth.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market
Challenges Facing the Market
Despite these growth factors, the anti-diuretic drugs market faces some challenges. One of the major restraints is the potential side effects of vasopressin, which can lead to complications such as asthma, heart disease, and heart failure. These risks may cause patients to be hesitant about undergoing treatment, thereby limiting the market's growth.
Market Segmentation Insights
In terms of product types, the vasopressin segment accounted for the largest share of the market in 2023, largely due to its essential role in preventing dehydration by mimicking ADH's effect on the kidneys. Desmopressin, a synthetic form of vasopressin, is also expected to see strong growth due to its higher anti-diuretic effect and lower risk of side effects compared to vasopressin.
When it comes to applications, diabetes insipidus is the leading segment, accounting for the largest revenue share. The rising number of diabetes insipidus cases worldwide is expected to continue driving this segment's dominance in the market.
Distribution Channels
The hospital pharmacies segment led the market in 2023, benefiting from the increasing number of hospital admissions for urological conditions associated with diabetes insipidus. Meanwhile, the online pharmacy segment is expected to grow at a strong CAGR due to increasing internet penetration and the convenience of online drug purchases.
Anti-Diuretic Drugs Top Companies and Competitive Landscape
The global anti-diuretic drugs market is fairly fragmented, with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective solutions.
Some major players included in the global anti-diuretic drugs market report are:
Par Sterile Products, LLC.
Pfizer Inc.
ADH Health
Otsuka Holdings Co., Ltd.
Azevan Pharmaceuticals, Inc.
Taj Pharmaceuticals Limited.
Endo International
Ferring Pharmaceuticals
Fresenius Kabi.
Hybio Pharmaceutical.
Hainan Zhonghe Pharmaceutical.
Avadel
Hoffman-La Roche Ltd
CSL Limited.
Bayer
Eisai Co., Ltd.
Allergan
Sanofi S.A
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Other companies
Anti-Diuretic Drugs Latest Industry Updates
On February 2022, Dr. Reddy's Laboratories announced the launch of its authorized generic version of VASOSTRICT (vasopressin injection, USP) vials U.S. Market, to expand their geographical across U.S. The product is approved by the U.S. Food and Drug Administration (USFDA).
On February 25, 2020, Lupin announced the launch of Ethacrynic Acid Tablets USP, 25 mg, after the receiving approval from United States Food and Drug Administration (U.S. FDA)
Anti-Diuretic Drugs Market Segmentation Analysis
For the purpose of this report, Emergen Research has segmented global anti-diuretic drugs market on the basis of Type, Application, Distribution Channel, and region:
Type Outlook (Revenue, USD Million; 2020-2033)
Oxytocin
Vasopressin
Desmopressin
Application Outlook (Revenue, USD Million; 2020-2033)
Diabetes Insipidus
Hemophilia
Hypertension
Others
Distribution Channel Outlook (Revenue, USD Million; 2020-2033)
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2907
Regional Outlook (Revenue, USD Million; 2020-2033)
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Benelux
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
UAE
South Africa
Turkey
Rest of MEA
Anti-Diuretic Drugs Market Snapshots
Anti-Diuretic Drugs Market Size: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-size
Anti-Diuretic Drugs Market Share: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-share
Anti-Diuretic Drugs Market Trends: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-trends
Anti-Diuretic Drugs Regional Market Demand: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/regional-market-demand
Anti-Diuretic Drugs Market Analysis: https://www.emergenresearch.com/industry-report/anti-diuretic-drugs-market/market-analysis
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Diuretic Drugs Market: 2024 Industry Size, Shares, Segment & Forecast up to 2032 here
News-ID: 3676688 • Views: …
More Releases from Emergen Research
Europe Industrial Tubes, Pipes, Fittings and Flanges Market Size to Boost USD 30 …
The Europe industrial tubes, pipes, fittings and flanges market size was USD 179.94 Billion in 2023 and is expected to register a rapid revenue CAGR of 5.23% during the forecast period. Growing demand from major industries such as oil & gas, construction, and automotive, increasing infrastructural development projects, and rising investments in pipeline infrastructure for oil and gas transportation are major factors driving market revenue growth are key factors driving…
Staple Fiber Market Size to Boost USD 102.92 Billion By 2033 | CAGR 7.6% - Publi …
The Staple Fiber Market size was USD 49.58 billion in 2023 and is expected to register a revenue CAGR of 7.6% during the forecast period. Customer preferences are evolving, demand for affordable Fibers is rising, and an increase in demand from the automobile sector are some of the major factors driving the Staple Fiber Markets revenue growth.
The staple fiber market is a significant segment of the global textile industry, comprising…
Chemical Indicator Inks Market Size to Boost USD 124.6 Million By 2033 | CAGR 6. …
The global Chemical indicator inks market size was USD 64.6 Million in 2023 and is expected to register a revenue CAGR of 6.9% during the forecast period. Increasing demand for sterile packaging from the food and beverage industry, growing adoption of health and hygiene products by consumers, rising cases of nosocomial infections and illness across the globe and rising R&D expenditure for development of efficient products used in sterilization procedures…
Blood Pressure Transducers Market Size to Boost USD 2671.3 Million By 2033 | CAG …
Global blood pressure transducers market size reached USD 911.1 Million in 2023 and is expected to register a revenue CAGR of 11.6% during the forecast period. Increasing prevalence of hypertension and rising the tendency of sedentary lifestyle and rapid technological advancement in transducers are key factors driving the market revenue growth. Blood pressure transducers are used in Intravascular and extravascular blood pressure. These transducers can transmit blood pressure data wirelessly…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
